Form 4 for EDIT Editas Medicine, Inc.
Accepted 2021-10-20 00:00:00 ET · period of report 2021-10-18 · accession 0001179110-21-009557 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-20 | 2021-10-18 | EDIT | MULLEN JAMES C | CEO, Dir | S - Sale | $38.03 | -13.8K | 57.7K | -19% | -$525.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-18 | S | D | 13,805 | $38.03 | 57,673 | D | — | — |